Here are Steven’s Poster Picks for Monday, May 6, 2019:
Migraine
- Long-term data for frenezumab (P2.10-002, P2.10-008, P2.10-015) and galcanezumab (P2.10-010)
- Safety of ubrogepant (P2.10-003, P2.10-009)
Parkinson’s disease
- Levodopa inhalation powder (P2.8-048): sublingual apomorphine (P2.8-053)
- Suicidal behaviour (P2.8-025)
Multiple sclerosis – Basic science
- Bruton’s tyrosine kinase inhibition (P2.2-063, P2.2-077)
- Myelin-reactive CD8+ T cells (P2.2-065)
- DMF and IgG (P2.2-069), and GM-CSF-producing Th1 cells (P2.2-071)
- PPMS: and antibodies (P2.2-073); and NfL (P2.2-082); and CSF (P2.2-092)
Traumatic brain injury
- Brain volume loss (P2.9-045)
- Fluid/MRI biomarkers (P2.9-057)